Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Palonosetron (ATC-Code nach WHO: A04AA05)
Description
The subject of this publication is the conclusion of non-exclusive discount agreements under § 130a para. 8 SGB V for medicines with the active substance Palonosetron (ATC code according to WHO: A04AA05). The contract will be concluded within the framework of an "Open-House" model, i.e. a contract conclusion is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations will not be conducted and there will be no (supply) exclusivity. It is pointed out that the quantity to be procured is unknown, as it depends on demand and the development of the number of insured persons, the prescribing behaviour of doctors and the dispensing and stocking behaviour of public pharmacies. Minimum procurement quantities are therefore not guaranteed. Interested pharmaceutical companies can download the participation documents from the project room of the German TED portal (DTVP). To do this, an application for access to the project room is first required. After the applicant has been granted access by the contracting authority, the participation documents can be accessed. Absolute confidentiality must be maintained regarding the content of the participation documents - in particular regarding the content of the discount agreement and the discounts mentioned therein. Full or partial disclosure or provision of contents of the participation documents to or for third parties requires the prior written consent of the contracting authority. If participation is waived, all documents must be destroyed immediately in accordance with data protection regulations. The documents to be submitted are listed in the documents "Cover Letter" and "Explanation of the Contract Terms" deposited in the project room. Communication, including the transmission of the participation documents, will be carried out electronically via the tendering portal DTVP; further details can be found in the aforementioned documents. Any differing information in the contract notice is due to technical reasons and is not binding. Participation applications can be submitted for the first time by 5 March 2026. All further submission deadlines can be found in the attachment "Submission Deadlines" deposited in the project room. If the deadline for submission falls on a Saturday, Sunday or a public holiday throughout Germany, the following working day shall apply. If the submission is received late, the submitted applications will be considered for the next submission deadline. The discount agreement will end, regardless of the date of the contract conclusion, at the latest on 31 March 2028. The contracting authority reserves the right to terminate the open-house procedure prematurely, in particular in the event of the conclusion of exclusive discount agreements; in this case, the discount agreements already concluded will end in accordance with the contractual provisions. According to the experience of the contracting authority, exclusive discount agreements generally come into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Diagnostic ultrasound devices – Rahmenvereinbarung Ultraschallgeräte
Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH und der AGKAMED GmbHGermanyDiagnostic ultrasound devicesDeadline in 37 daysPublished on Sep 14, 2026
Germany – Medical breathing devices – Beatmungsgeräte
Land Hessen, vertreten durch das Hessische Competence Center -Beschaffungen-GermanyMedical breathing devicesDeadline in 27 daysPublished on Sep 14, 2026
Germany – X-ray contrast media – Abschluss von Rahmenverträgen zur Belieferung der radiologisch tätigen Vertragsärzte in den Bereichen der KV Schleswig-Holstein und in den Ländern Rheinland-Pfalz und Saarland mit Kontrastmitteln
AOK NordWest - Die Gesundheitskasse.GermanyX-ray contrast mediaReagents and contrast mediaDeadline in 29 daysPublished on Sep 14, 2026
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Cefuroxim in parenteraler Darreichungsform (ATC-Code: J01DC02).
AOK Niedersachsen. Die Gesundheitskasse.GermanyPharmaceutical productsDeadline in 712 daysPublished on Sep 14, 2026